Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$2.1.

  • Abivax's EPS (Weighted Average and Diluted) fell 14069.1% to -$2.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1, marking a year-over-year decrease of 14069.1%. This contributed to the annual value of -$2.8 for FY2024, which is 2465.73% up from last year.
  • Abivax's EPS (Weighted Average and Diluted) amounted to -$2.1 in Q3 2025, which was down 14069.1% from -$0.76 recorded in Q2 2025.
  • Over the past 5 years, Abivax's EPS (Weighted Average and Diluted) peaked at -$0.62 during Q4 2024, and registered a low of -$63096.4 during Q1 2025.